Skip to main content
    Z

    Zentalis Pharmaceuticals Llc (ZNTL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.60
    -0.10 (-5.88%)

    Market Cap: $167.05M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zentalis Pharmaceuticals Llc (ZNTL) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Zentalis Pharmaceuticals Llc (ZNTL) is expected to report earnings on Mar 24, 2027. In the quarter ended Sep 30, 2026, Zentalis Pharmaceuticals Llc reported EPS of -$0.34, above the -$0.58 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    44%(12/27)
    Avg Surprise
    -15.21%
    Streak
    1 Q

    Upcoming Estimates

    Reports Mar 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.41
    Range-$0.59 - -$0.33
    13 analysts
    Revenue Consensus
    N/A
    RangeN/A
    11 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.49
    Range-$0.63 - -$0.43
    4 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.62+21.4%
    60d ago-$0.62+21.4%
    30d ago-$0.62+21.4%
    7d ago-$0.58+14.8%
    Current-$0.49
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    ZNTL has an expected report date of Mar 24, 2027.

    Earnings History

    Of the 27 quarters below that had an estimate, ZNTL beat 12 and missed 15. The widest gap in the table came in the quarter ended Mar 31, 2020, when EPS landed 512.77% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.34-$0.58-$0.63 - -$0.42+41.38%BeatN/A82 up, 0 downNov 9, 2026
    Jun 30, 2026-$0.59-$0.45-$0.61 - -$0.30-31.11%MissN/A80 up, 0 downAug 6, 2026
    Mar 31, 2026-$0.50-$0.47N/A-7.43%MissN/A30 up, 1 downMay 12, 2026
    Dec 31, 2025-$0.49-$0.61-$1.80 - -$0.25+19.67%BeatN/A73 up, 0 downMar 26, 2026
    Sep 30, 2025-$0.37-$0.48-$0.57 - -$0.38+22.92%BeatN/A75 up, 1 downNov 10, 2025
    Jun 30, 2025-$0.37-$0.52-$0.81 - -$0.43+28.85%BeatN/A74 up, 1 downAug 6, 2025
    Mar 31, 2025-$0.67-$0.61-$0.69 - -$0.52-9.84%Miss-578.6%70 up, 2 downMay 14, 2025
    Dec 31, 2024-$0.61-$0.68-$0.99 - -$0.47+9.96%BeatN/A104 up, 0 downMar 26, 2025
    Sep 30, 2024-$0.56-$0.87-$0.99 - -$0.81+35.63%BeatN/A90 up, 0 downNov 12, 2024
    Jun 30, 2024-$1.24-$0.83-$0.98 - -$0.47-49.40%MissN/A110 up, 0 downAug 9, 2024
    Mar 31, 2024$0.14-$0.74-$0.96 - -$0.39+118.92%BeatN/A100 up, 0 downMay 7, 2024
    Dec 31, 2023-$0.93-$0.92-$1.54 - -$0.61-1.09%MissN/A110 up, 0 downFeb 27, 2024
    Sep 30, 2023-$0.79-$0.94-$1.24 - -$0.76+15.96%BeatN/A102 up, 0 downNov 6, 2023
    Jun 30, 2023-$1.85-$1.02-$1.15 - -$0.90-81.37%MissN/A100 up, 0 downAug 9, 2023
    Mar 31, 2023-$1.07-$1.03-$1.44 - -$0.87-3.88%MissN/A90 up, 0 downMay 10, 2023
    Dec 31, 2022-$0.92-$1.06-$1.67 - -$0.93+13.21%BeatN/A110 up, 0 downMar 1, 2023
    Sep 30, 2022-$0.96-$1.19-$1.41 - -$1.01+19.33%BeatN/A90 up, 0 downNov 9, 2022
    Jun 30, 2022-$1.34-$1.20-$1.32 - -$1.02-11.67%MissN/A91 up, 0 downAug 9, 2022
    Mar 31, 2022-$1.31-$1.20-$1.39 - -$1.08-9.17%MissN/A102 up, 0 downMay 5, 2022
    Dec 31, 2021-$1.11-$1.49-$1.59 - -$1.30+25.50%BeatN/A70 up, 0 downFeb 24, 2022
    Sep 30, 2021-$0.09-$1.25-$1.43 - -$0.78+92.80%BeatN/A62 up, 0 downNov 10, 2021
    Jun 30, 2021-$1.34-$1.16-$1.34 - -$0.93-15.52%MissN/A6N/AAug 12, 2021
    Mar 31, 2021-$1.24-$0.91-$1.06 - -$0.86-36.26%MissN/A5N/AMay 17, 2021
    Dec 31, 2020-$1.01-$0.95-$1.16 - -$0.66-6.32%MissN/A5N/AMar 25, 2021
    Sep 30, 2020-$0.91-$0.76N/A-19.74%MissN/A3N/ANov 9, 2020
    Jun 30, 2020-$0.78-$0.49-$0.58 - -$0.41-59.18%MissN/A3N/AAug 13, 2020
    Mar 31, 2020-$2.88-$0.47-$0.96 - -$0.47-512.77%MissN/A4N/AApr 6, 2020
    Last 27 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.90, after -$2.27 the year before. It was -$5.58 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.90N/A
    Dec 31, 2024-$2.27N/A
    Dec 31, 2023-$4.64N/A
    Dec 31, 2022-$4.53N/A
    Dec 31, 2021-$3.78N/A
    Dec 31, 2020-$5.58N/A

    Frequently Asked Questions About ZNTL

    When is Zentalis Pharmaceuticals Llc's next earnings date?

    Zentalis Pharmaceuticals Llc's next earnings report is expected for Mar 24, 2027.

    Did ZNTL beat earnings estimates last quarter?

    Yes. Zentalis Pharmaceuticals Llc reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.58 estimate, a 41.38% surprise.

    What EPS do analysts expect from ZNTL next quarter?

    The consensus EPS estimate for Zentalis Pharmaceuticals Llc for the quarter ending Dec 31, 2026 is -$0.41 from 13 analysts, with estimates from -$0.59 to -$0.33.

    How often does ZNTL beat earnings estimates?

    Zentalis Pharmaceuticals Llc beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +9.30%.